Is Trident Texofab overvalued or undervalued?

Aug 19 2025 08:06 AM IST
share
Share Via
As of August 18, 2025, Trident Texofab is considered overvalued with a valuation grade of "expensive," highlighted by a PE ratio of 115.12, significantly higher than its peers, despite a strong 1-year stock return of 387.45%.
As of 18 August 2025, Trident Texofab's valuation grade has moved from very expensive to expensive, indicating a slight improvement in its perceived value. The company is currently considered overvalued. Key ratios include a PE ratio of 115.12, an EV to EBITDA ratio of 67.10, and a PEG ratio of 5.47, all of which are significantly higher than industry norms.

In comparison to its peers, Trident Texofab's PE ratio is notably higher than Lloyds Enterprises at 35.13 and PTC India at 8.88, further emphasizing its overvaluation. Additionally, while Trident has shown impressive stock performance with a 1-year return of 387.45%, this does not mitigate the concerns regarding its high valuation ratios. Overall, the company's financial metrics suggest that it is trading at a premium compared to its peers in the garments and apparels industry.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Trident Texofab falling/rising?
Dec 17 2025 01:14 AM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Dec 05 2025 08:41 AM IST
share
Share Via
Is Trident Texofab technically bullish or bearish?
Dec 04 2025 08:47 AM IST
share
Share Via
How has been the historical performance of Trident Texofab?
Dec 03 2025 10:55 PM IST
share
Share Via
Is Trident Texofab overvalued or undervalued?
Nov 19 2025 08:10 AM IST
share
Share Via